Drug-containing serum of Xinfeng capsules protect against H9C2 from death by enhancing miRNA-21 and inhibiting toll-like receptor 4/phosphorylated p-38 (p-p38)/p-p65 signaling pathway and proin-flammatory cytokines expression-MedSci.cn

Drug-containing serum of Xinfeng capsules protect against H9C2 from death by enhancing miRNA-21 and inhibiting toll-like receptor 4/phosphorylated p-38 (p-p38)/p-p65 signaling pathway and proin-flammatory cytokines expression

Cao, YX; Guo, YK; Zong, RK; Huang, CB; Wang, Y; Liu, J

Wang, Y (reprint author), Nanjing Univ Tradit Chinese Med, Clin Sch 1, Nanjing 210046, Jiangsu, Peoples R China.; Liu, J (reprint author), Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Rheumatol, Hefei 230031, Anhui, Peoples R China.

Abstract

OBJECTIVE: To investigate effect of drug-containing serum of Xinfeng capsules on myocardial cell growth. METHODS: Drug-containing serum of Xinfeng cap......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Drug-containing serum of Xinfeng capsules protect against H9C2 from death by enhancing miRNA-21 and inhibiting toll-like receptor 4/phosphorylated p-38 (p-p38)/p-p65 signaling pathway and proin-flammatory cytokines expression

科室

工具

服务